Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · IEX Real-Time Price · USD
0.369
-0.011 (-2.97%)
At close: May 2, 2024, 4:00 PM
0.357
-0.011 (-3.06%)
After-hours: May 2, 2024, 7:59 PM EDT

Senti Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020
Market Capitalization
172962291-
Market Cap Growth
--52.46%-78.72%--
Enterprise Value
1528-3254-17
PE Ratio
-0.41-0.41-1.06-5.25-
PS Ratio
6.5911.4814.43105.23-
PB Ratio
0.250.440.49-2.61-
P/FCF Ratio
-0.46-0.46-0.81-7.23-
P/OCF Ratio
-0.56-0.56-1.77-8.39-
EV/Sales Ratio
5.8910.78-0.7091.98-30.01
EV/EBITDA Ratio
-0.42-0.420.06-4.860.95
EV/EBIT Ratio
-0.39-0.390.05-4.590.86
EV/FCF Ratio
-0.43-0.430.04-6.320.67
Debt / Equity Ratio
0.560.560.29-0.20-0.24
Debt / EBITDA Ratio
-0.57-0.57-0.68-0.43-0.79
Debt / FCF Ratio
-0.59-0.59-0.49-0.57-0.55
Quick Ratio
3.123.125.684.116.40
Current Ratio
5.625.625.684.146.52
Asset Turnover
0.020.020.030.02-
Return on Equity (ROE)
-79.00%-79.00%-736.60%178.20%-
Return on Assets (ROA)
-51.10%-51.10%-42.00%-39.50%-
Return on Capital (ROIC)
-88.67%-88.67%-37.77%45.59%55.29%
Earnings Yield
-421.21%-241.70%-94.13%-19.04%-
FCF Yield
-381.32%-218.80%-123.34%-13.83%-
Buyback Yield / Dilution
-69.94%-69.94%-796.58%78.99%-
Total Shareholder Return
-69.94%-69.94%-796.58%78.99%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).